BVS 7.34 (+1.1%)
US09075A1088Medical Diagnostics & ResearchDiagnostics & Research

Bioventus (BVS) Competitor Comparison

We are evaluating the key criteria listed to compare Bioventus (BVS) against its competitors in the Diagnostics & Research industry.

Performance 3 years - BVS ranking 31 / 58

These are the competitors of Bioventus in the industry Diagnostics & Research ranked by performance 3 years
1. Natera NTRA
334.39
2. Meridian Bioscience VIVO
246.63
3. RadNet RDNT
164.07
4. Medpace Holdings MEDP
114.05
5. Lantheus Holdings LNTH
62.23
6. Heska HSKA
41.31
7. Twist Bioscience TWST
36.16
8. Quest Diagnostics DGX
28.4
9. Sera Prognostics SERA
22.27
10. PerkinElmer PKI
21.19
11. IDEXX Laboratories IDXX
18.77
12. Laboratory Corp of America Holdings LH
14.13
13. Ortho Clinical Diagnostics Holdings OCDX
13.74
14. Waters WAT
3.41
15. Exagen XGN
-1.63
16. Exact Sciences EXAS
-8.08
17. Qiagen QGEN
-8.17
18. Anixa Biosciences ANIX
-10.61
19. Agilent Technologies A
-13.04
20. Danaher DHR
-13.07
21. NeoGenomics NEO
-18.95
22. Syneos Health SYNH
-19.01
23. Guardant Health GH
-19.91
24. DexCom DXCM
-19.93
25. Mettler-Toledo MTD
-20.19
26. Olink Holding OLK
-22.2
27. Thermo Fisher Scientific TMO
-24.59
28. Personalis PSNL
-24.77
29. IQVIA Holdings IQV
-31.19
30. Icon ICLR
-38.06
31. Bioventus BVS
-39.49
32. Sotera Health SHC
-41.67
33. MaxCyte MXCT
-48.07
34. CareDx CDNA
-50.53
35. Charles River Laboratories CRL
-53.61
36. Fulgent Genetics FLGT
-62.28
37. National Research NRC
-62.57
38. Psychemedics PMD
-62.78
39. Myriad Genetics MYGN
-62.89
40. Precipio PRPO
-65.79
41. Global Cord Blood CO
-67.25
42. Enzo Biochem ENZ
-70.36
43. Biodesix BDSX
-72.97
44. Illumina ILMN
-73.7
45. Neogen NEOG
-78.37
46. MDxHealth MDXH
-79.95
47. Pacific Biosciences of California PACB
-82.03
48. Inotiv NOTV
-85.61
49. bioAffinity Technologies BIAF
-88.45
50. Co-Diagnostics CODX
-88.94
51. Trinity Biotech TRIB
-89.06
52. Organovo Holdings ONVO
-89.19
53. Interpace Biosciences IDXG
-89.51
54. Neuronetics STIM
-91.07
55. DarioHealth DRIO
-93.77
56. Prenetics Global PRE
-95.42
57. SeqLL SQL
-95.69
58. Aspira Womens Health AWH
-98.83

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.